ResearcherSamsung Medical CenterActive in the last 2 years
Kangpyo Kim
Matched on ORCID iD 0000-0002-5871-8846; OpenAlex author ID A5008414475. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2024: 1 paper · 2025: 1 paper
Papers 2
- Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. Co-author DOI 10.1002/jcsm.13643↗
- Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy. Co-author DOI 10.1016/j.ctro.2024.100732↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin Seok Heo · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- In Woong Han · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Jong Kyun Lee · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Sang Hyun Shin · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Ji Hye Min · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Hee Chul Park · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Jung Yong Hong · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Kyu Taek Lee · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Joo Kyung Park · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Joon Oh Park · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Jeong Il Yu · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Sook‐Young Woo · 1 shared paper, 2025 · strength 0.20
- Hongbeom Kim · 1 shared paper, 2025 · strength 0.20
- Jin Ho Choi MD · 1 shared paper, 2025 · strength 0.20
- Kyunga Kim · 1 shared paper, 2024 · strength 0.18
- Kwang Hyuck Lee · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.